Topics
March 2012 | Perspectives: from The Editors Of New Retina Md
The Sunshine Act's Intimidation Factor
Will the noble objectives of this law set up a roadblock to innovation?
Richard S. Kaiser, MD, and Jonathan L. Prenner, MD
May 13, 2026
NeuroVision Acquires Durin Life Sciences to Expand Neurodegenerative Disease Diagnostics Platform
Study: Popular GLP-1 Drugs Linked to Certain Optic Nerve Disorders
May 12, 2026
Astellas Presents New Izervay Data Showing Reduced Risk of Losing Driving Eligibility in GA Patients
AMA Unveils New Policy Framework to Combat AI “Deepfake” Impersonation of Physicians
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
